For instance, in a study [87] involving both LUSC and lung adenocarcinoma tissues from lung cancer patients, PIK3CA mutations were found in 9% of LUSC patients and 0% of adenocarcinoma patients. This evidence concerns the gene PIK3CA and lung cancer.